TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
GlaxoSmithKline AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
87,690
|
80,342
|
81,036 |
| Financial expenses |
162
|
79
|
29 |
| Earnings before taxes |
2,945
|
2,472
|
2,655 |
| Total assets |
26,737
|
25,979
|
25,852 |
| Current assets |
19,600
|
18,713
|
18,555 |
| Current liabilities |
16,768
|
15,634
|
14,805 |
| Equity capital |
9,970
|
10,345
|
11,047 |
| - share capital |
80
|
85
|
90 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
37.3%
|
39.8%
|
42.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
3.4%
|
3.1%
|
3.3% |
| Return on assets (ROA) |
11.6%
|
9.8%
|
10.4% |
| Current ratio |
116.9%
|
119.7%
|
125.3% |
| Return on equity (ROE) |
29.5%
|
23.9%
|
24.0% |
| Change turnover |
11,454
|
4,455
|
6,731 |
| Change turnover % |
15%
|
6%
|
9% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.